“Open-Label Extension Study Evaluating the Long-Term Safety, Efficacy, and Tolerability of FMX103 1.5% Topical Minocycline Foam in the Treatment of Moderate-to-Severe Facial Papulopustular Rosacea”. 2020. SKIN The Journal of Cutaneous Medicine 4 (5): s54. https://doi.org/10.25251/skin.4.supp.53.